References - SPS

The American College of Chest Physicians (ACCP) recommends monitoring of anti-factor Xa levels should be considered in patients with severe RI if LMWHs are used (3). An effective therapeutic range has not been clearly defined, but, peak levels measured four hours post dose, seem to have a stronger correlation with safety and efficacy than ... ................
................